| Name | Ascension At Home |
|---|---|
| Location | 6840 Logan Dr Ste F, Evansville, Indiana |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Medical Social Services Home Health Aide |
| Medicare ID | 157281 |
| Ownership Type | Voluntary Non-profit - Other |
| Service Area Zip Codes | 47523, 47537, 47550, 47584, 47586, 47590, 47598, 47601, 47610, 47611, 47613, 47615, 47619, 47620, 47630, 47631, 47633, 47634, 47635, 47637, 47638, 47639, 47648, 47649, 47660, 47665, 47666, 47670, 47708, 47710, 47711, 47712, 47713, 47714, 47715, 47719, 47720, 47725, 47801 |
| NPI Number | 1780687061 |
| Organization Name | ST. MARY'S AT HOME, LLC |
| Doing Business As | ASCENSION AT HOME |
| Address | 7321 Eagle Crest Blvd Ste B, Evansville, IN 47715 |
| Phone Number | 812-774-9760 |
News Archive
International non-profit organization FightSMA will be hosting highly respected experts from across the country on Thursday, May 5, 2011 for a series of panel discussions, Thriving with SMA: LIVE!.
Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today that it has signed a supply agreement with Actavis, one of the world's leading generic pharmaceutical companies, for the future manufacturing of Reteplase.
St. Jude Medical, Inc., a global medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) approval for its Trifecta™ valve. The valve, a clinically-proven replacement for diseased, damaged or malfunctioning aortic heart valves, mimics the flow of a natural, healthy heart and represents a significant new product in the pericardial aortic stented tissue valve market.
Patients trying to navigate today's complex medical system with its costly laboratory analyses might prefer a pain-free home diagnostic device, worn on the wrist, that can analyze, continuously record and immediately remedy low electrolyte levels.
› Verified 5 days ago
| Quality Rating: |
News Archive
International non-profit organization FightSMA will be hosting highly respected experts from across the country on Thursday, May 5, 2011 for a series of panel discussions, Thriving with SMA: LIVE!.
Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today that it has signed a supply agreement with Actavis, one of the world's leading generic pharmaceutical companies, for the future manufacturing of Reteplase.
St. Jude Medical, Inc., a global medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) approval for its Trifecta™ valve. The valve, a clinically-proven replacement for diseased, damaged or malfunctioning aortic heart valves, mimics the flow of a natural, healthy heart and represents a significant new product in the pericardial aortic stented tissue valve market.
Patients trying to navigate today's complex medical system with its costly laboratory analyses might prefer a pain-free home diagnostic device, worn on the wrist, that can analyze, continuously record and immediately remedy low electrolyte levels.
› Verified 5 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 98.1 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.1 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.7 | 99.6 |
| How often the home health team checked patients for depression | 99.8 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 82.5 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 82.2 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 98.3 | 96.4 |
News Archive
International non-profit organization FightSMA will be hosting highly respected experts from across the country on Thursday, May 5, 2011 for a series of panel discussions, Thriving with SMA: LIVE!.
Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today that it has signed a supply agreement with Actavis, one of the world's leading generic pharmaceutical companies, for the future manufacturing of Reteplase.
St. Jude Medical, Inc., a global medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) approval for its Trifecta™ valve. The valve, a clinically-proven replacement for diseased, damaged or malfunctioning aortic heart valves, mimics the flow of a natural, healthy heart and represents a significant new product in the pericardial aortic stented tissue valve market.
Patients trying to navigate today's complex medical system with its costly laboratory analyses might prefer a pain-free home diagnostic device, worn on the wrist, that can analyze, continuously record and immediately remedy low electrolyte levels.
› Verified 5 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 80.4 | 79.6 |
| How often patients got better at getting in and out of bed | 80.9 | 81.1 |
| How often patients got better at bathing | 83.4 | 82.3 |
| How often patients’ breathing improved | 81 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 93.2 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 69.5 | 75 |
| How often home health patients had to be admitted to the hospital | 15.9 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 11.2 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 77 | 94 |
News Archive
International non-profit organization FightSMA will be hosting highly respected experts from across the country on Thursday, May 5, 2011 for a series of panel discussions, Thriving with SMA: LIVE!.
Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today that it has signed a supply agreement with Actavis, one of the world's leading generic pharmaceutical companies, for the future manufacturing of Reteplase.
St. Jude Medical, Inc., a global medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) approval for its Trifecta™ valve. The valve, a clinically-proven replacement for diseased, damaged or malfunctioning aortic heart valves, mimics the flow of a natural, healthy heart and represents a significant new product in the pericardial aortic stented tissue valve market.
Patients trying to navigate today's complex medical system with its costly laboratory analyses might prefer a pain-free home diagnostic device, worn on the wrist, that can analyze, continuously record and immediately remedy low electrolyte levels.
› Verified 5 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
International non-profit organization FightSMA will be hosting highly respected experts from across the country on Thursday, May 5, 2011 for a series of panel discussions, Thriving with SMA: LIVE!.
Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today that it has signed a supply agreement with Actavis, one of the world's leading generic pharmaceutical companies, for the future manufacturing of Reteplase.
St. Jude Medical, Inc., a global medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) approval for its Trifecta™ valve. The valve, a clinically-proven replacement for diseased, damaged or malfunctioning aortic heart valves, mimics the flow of a natural, healthy heart and represents a significant new product in the pericardial aortic stented tissue valve market.
Patients trying to navigate today's complex medical system with its costly laboratory analyses might prefer a pain-free home diagnostic device, worn on the wrist, that can analyze, continuously record and immediately remedy low electrolyte levels.
› Verified 5 days ago
The patient survey data of Ascension At Home is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 91 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 87 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 86 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 90 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 84 | 78 |
News Archive
International non-profit organization FightSMA will be hosting highly respected experts from across the country on Thursday, May 5, 2011 for a series of panel discussions, Thriving with SMA: LIVE!.
Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today that it has signed a supply agreement with Actavis, one of the world's leading generic pharmaceutical companies, for the future manufacturing of Reteplase.
St. Jude Medical, Inc., a global medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) approval for its Trifecta™ valve. The valve, a clinically-proven replacement for diseased, damaged or malfunctioning aortic heart valves, mimics the flow of a natural, healthy heart and represents a significant new product in the pericardial aortic stented tissue valve market.
Patients trying to navigate today's complex medical system with its costly laboratory analyses might prefer a pain-free home diagnostic device, worn on the wrist, that can analyze, continuously record and immediately remedy low electrolyte levels.
› Verified 5 days ago
Deaconess Vna Location: 610 E Walnut St Po Box 3487, Evansville, Indiana 47734 Ratings: Phone: (812) 425-3561 | |
Pediatric Nursing Specialists Of Indiana Location: 5200 Washington Avenue Suite C, Evansville, Indiana 47715 Ratings: NA Phone: (812) 401-6990 | |
Ascension At Home Location: 6840 Logan Dr Ste F, Evansville, Indiana 47715 Ratings: Phone: (812) 774-7960 | |
Specialty Home Health Care Inc Location: 331 Kimber Ln Dept A, Evansville, Indiana 47715 Ratings: Phone: (812) 476-5404 | |
Deaconess Home Health, Llc Location: 2504 Waterbridge Way, Evansville, Indiana 47710 Ratings: Phone: (812) 425-3561 | |
Omni Home Care Location: 600 N Weinback Ave Ste 610, Evansville, Indiana 47711 Ratings: Phone: (812) 479-6664 |